One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial

By sjmartinez • June 7, 2023

Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ; ACTIV-2/A5401 Study Team. One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial. Clin Infect Dis. 2023 Jun 5:ciad342. doi: 10.1093/cid/ciad342. Epub ahead of print. PMID: 37279602.

Tags: camostat, covid-19, Infectious Diseases, outpatient, phase 2, Publications, SARS-CoV-2

The Use of Next-Generation Sequencing to Assist in the Diagnosis of Atypical Vasculitis

Chetrit DA, Aung T, Cheng QJ, King J. The Use of Next-Generation Sequencing to Assist in the Diagnosis of Atypical Vasculitis. Cureus. 2024 Nov 7;16(11):e73247.[...]

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks

Yarava A, Marshall C, Reichert DE, Ye A, Khanal P, Robbins SH, Sachais BS, Oh D, Metcalf RA, Conry-Cantilena K, King K, Reyes M, Adamski[...]

When Can a MRSA Nares Swab Guide Antibiotic Stewardship?: What the Nose Knows

Saito AK, Goetz MB, Wu S. When Can a MRSA Nares Swab Guide Antibiotic Stewardship?: What the Nose Knows. JAMA Intern Med. 2024 Dec 9.[...]